Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
2.
Br J Cancer ; 106(11): 1807-15, 2012 May 22.
Artículo en Inglés | MEDLINE | ID: mdl-22531632

RESUMEN

BACKGROUND: Cellular quiescence is a state of reversible proliferation arrest that is induced by anti-mitogenic signals. The endogenous cardiac glycoside ouabain is a specific ligand of the ubiquitous sodium pump, Na,K-ATPase, also known to regulate cell growth through unknown signalling pathways. METHODS: To investigate the role of ouabain/Na,K-ATPase in uncontrolled neuroblastoma growth we used xenografts, flow cytometry, immunostaining, comet assay, real-time PCR, and electrophysiology after various treatment strategies. RESULTS: The ouabain/Na,K-ATPase complex induced quiescence in malignant neuroblastoma. Tumour growth was reduced by >50% when neuroblastoma cells were xenografted into immune-deficient mice that were fed with ouabain. Ouabain-induced S-G2 phase arrest, activated the DNA-damage response (DDR) pathway marker γH2AX, increased the cell cycle regulator p21(Waf1/Cip1) and upregulated the quiescence-specific transcription factor hairy and enhancer of split1 (HES1), causing neuroblastoma cells to ultimately enter G0. Cells re-entered the cell cycle and resumed proliferation, without showing DNA damage, when ouabain was removed. CONCLUSION: These findings demonstrate a novel action of ouabain/Na,K-ATPase as a regulator of quiescence in neuroblastoma, suggesting that ouabain can be used in chemotherapies to suppress tumour growth and/or arrest cells to increase the therapeutic index in combination therapies.


Asunto(s)
Histonas/metabolismo , Neuroblastoma/metabolismo , Ouabaína/metabolismo , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Animales , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Ensayo Cometa , Femenino , Citometría de Flujo , Humanos , Ratones , Ratones Desnudos , Ouabaína/farmacología , Reacción en Cadena en Tiempo Real de la Polimerasa , Trasplante Heterólogo
3.
Cell Death Differ ; 15(12): 1857-64, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-18806756

RESUMEN

Apoptosis-inducing factor (AIF), a flavoprotein with NADH oxidase activity anchored to the mitochondrial inner membrane, is known to be involved in complex I maintenance. During apoptosis, AIF can be released from mitochondria and translocate to the nucleus, where it participates in chromatin condensation and large-scale DNA fragmentation. The mechanism of AIF release is not fully understood. Here, we show that a prolonged ( approximately 10 min) increase in intracellular Ca(2+) level is a prerequisite step for AIF processing and release during cell death. In contrast, a transient ATP-induced Ca(2+) increase, followed by rapid normalization of the Ca(2+) level, was not sufficient to trigger the proteolysis of AIF. Hence, import of extracellular Ca(2+) into staurosporine-treated cells caused the activation of a calpain, located in the intermembrane space of mitochondria. The activated calpain, in turn, cleaved membrane-bound AIF, and the soluble fragment was released from the mitochondria upon outer membrane permeabilization through Bax/Bak-mediated pores or by the induction of Ca(2+)-dependent mitochondrial permeability transition. Inhibition of calpain, or chelation of Ca(2+), but not the suppression of caspase activity, prevented processing and release of AIF. Combined, these results provide novel insights into the mechanism of AIF release during cell death.


Asunto(s)
Factor Inductor de la Apoptosis/metabolismo , Calcio/metabolismo , Calpaína/metabolismo , Espacio Intracelular/metabolismo , Mitocondrias/enzimología , Acrilatos/farmacología , Animales , Calpaína/antagonistas & inhibidores , Muerte Celular/efectos de los fármacos , Línea Celular Tumoral , Citocromos c/metabolismo , Activación Enzimática/efectos de los fármacos , Humanos , Espacio Intracelular/efectos de los fármacos , Ratones , Mitocondrias/efectos de los fármacos , Mitocondrias/metabolismo , Modelos Biológicos , Estaurosporina/farmacología
4.
J Endocrinol ; 184(2): 371-9, 2005 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-15684345

RESUMEN

Ca2+ oscillations are one of the most important signals within the cell. The mechanism for generation of Ca2+ oscillations is still not yet fully elucidated. We studied the role of capacitative Ca2+ entry (CCE) on intracellular Ca2+ oscillations induced by testosterone at the single-cell level in primary myotubes. Testosterone (100 nM) rapidly induced an intracellular Ca2+ rise, accompanied by Ca2+ oscillations in a majority of myotubes. Spectral analysis of the Ca2+ oscillations revealed a periodicity of 20.3 +/- 1.8 s (frequency of 49.3 +/- 4.4 mHz). In Ca(2+)-free medium, an increase in intracellular Ca2+ was still observed, but no oscillations. Neither nifedipine nor ryanodine affected the testosterone-induced Ca2+ response. This intracellular Ca2+ release was previously shown in myotubes to be dependent on inositol-1,4,5-trisphosphate (IP3). Intracellular Ca2+ store depletion in Ca(2+)-free medium, using a sarcoplasmic/endoplasmic reticulum calcium ATPase-pump inhibitor, followed by re-addition of extracellular Ca2+, gave a fast rise in intracellular Ca2+, indicating that CCE was present in these myotubes. Application of either testosterone or albumin-bound testosterone induced Ca2+ release and led to CCE after re-addition of Ca2+ to Ca(2+)-free extracellular medium. The CCE blockers 2-aminoethyl diphenylborate and La3+, as well as perturbation of the cytoskeleton by cytochalasin D, inhibited testosterone-induced Ca2+ oscillations and CCE. The steady increase in Ca2+ induced by testosterone was not, however, affected by either La3+ or cytochalasin D. These results demonstrate testosterone-induced Ca2+ oscillations in myotubes, mediated by the interplay of IP3-sensitive Ca2+ stores and Ca2+ influx through CCE.


Asunto(s)
Señalización del Calcio/efectos de los fármacos , Calcio/metabolismo , Líquido Intracelular/metabolismo , Fibras Musculares Esqueléticas/metabolismo , Testosterona/farmacología , Animales , Miembro Posterior , Procesamiento de Imagen Asistido por Computador , Microscopía Fluorescente , Músculo Esquelético , Ratas , Procesamiento de Señales Asistido por Computador , Técnicas de Cultivo de Tejidos
5.
Proc Natl Acad Sci U S A ; 98(23): 13420-4, 2001 Nov 06.
Artículo en Inglés | MEDLINE | ID: mdl-11687608

RESUMEN

The plant-derived steroid, digoxin, a specific inhibitor of Na,K-ATPase, has been used for centuries in the treatment of heart disease. Recent studies demonstrate the presence of a digoxin analog, ouabain, in mammalian tissue, but its biological role has not been elucidated. Here, we show in renal epithelial cells that ouabain, in doses causing only partial Na,K-ATPase inhibition, acts as a biological inducer of regular, low-frequency intracellular calcium ([Ca(2+)](i)) oscillations that elicit activation of the transcription factor, NF-kappa B. Partial inhibition of Na,K-ATPase using low extracellular K(+) and depolarization of cells did not have these effects. Incubation of cells in Ca(2+)-free media, inhibition of voltage-gated calcium channels, inositol triphosphate receptor antagonism, and redistribution of actin to a thick layer adjacent to the plasma membrane abolished [Ca(2+)](i) oscillations, indicating that they were caused by a concerted action of inositol triphosphate receptors and capacitative calcium entry via plasma membrane channels. Blockade of ouabain-induced [Ca(2+)](i) oscillations prevented activation of NF-kappa B. The results demonstrate a new mechanism for steroid signaling via plasma membrane receptors and underline a novel role for the steroid hormone, ouabain, as a physiological inducer of [Ca(2+)](i) oscillations involved in transcriptional regulation in mammalian cells.


Asunto(s)
Calcio/fisiología , Ouabaína/metabolismo , Transducción de Señal/fisiología , Animales , Western Blotting , Calcio/metabolismo , Células Cultivadas , Inmunohistoquímica , Túbulos Renales Proximales/citología , Túbulos Renales Proximales/enzimología , Túbulos Renales Proximales/metabolismo , Túbulos Renales Proximales/fisiología , Masculino , Microscopía Confocal , FN-kappa B/metabolismo , Ratas , Ratas Sprague-Dawley , ATPasa Intercambiadora de Sodio-Potasio/antagonistas & inhibidores , Fracciones Subcelulares/metabolismo
6.
Nature ; 405(6787): 694-7, 2000 Jun 08.
Artículo en Inglés | MEDLINE | ID: mdl-10864327

RESUMEN

Pyelonephritis is one of the most common febrile diseases in children. If not treated appropriately, it causes irreversible renal damage and accounts for a large proportion of end stage renal failures. Renal scarring can occur in the absence of inflammatory cells, indicating that bacteria may have a direct signalling effect on renal cells. Intracellular calcium ([Ca2+]i) oscillations can protect cells from the cytotoxic effects of prolonged increases in intracellular calcium. However, no pathophysiologically relevant protein that induces such oscillations has been identified. Here we show that infection by uropathogenic Escherichia coli induces a constant, low-frequency oscillatory [Ca2+]i response in target primary rat renal epithelial cells induced by the secreted RTX (repeats-in-toxin) toxin alpha-haemolysin. The response depends on calcium influx through L-type calcium channels as well as from internal stores gated by inositol triphosphate. Internal calcium oscillations induced by alpha-haemolysin in a renal epithelial cell line stimulated production of cytokines interleukin (IL)-6 and IL-8. Our findings indicate a novel role for alpha-haemolysin in pyelonephritis: as an inducer of an oscillating second messenger response in target cells, which fine-tunes gene expression during the inflammatory response.


Asunto(s)
Proteínas Bacterianas/fisiología , Calcio/metabolismo , Infecciones por Escherichia coli/microbiología , Proteínas de Escherichia coli , Escherichia coli/patogenicidad , Proteínas Hemolisinas/fisiología , Riñón/microbiología , Pielonefritis/microbiología , Animales , Bloqueadores de los Canales de Calcio/farmacología , Canales de Calcio Tipo L/metabolismo , Línea Celular , Células Epiteliales/microbiología , Infecciones por Escherichia coli/inmunología , Infecciones por Escherichia coli/metabolismo , Estrenos/farmacología , Femenino , Humanos , Interleucina-6/biosíntesis , Interleucina-8/biosíntesis , Riñón/citología , Nifedipino/farmacología , Pirrolidinonas/farmacología , Ratas , Ratas Sprague-Dawley
7.
Nat Neurosci ; 3(3): 226-30, 2000 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-10700253

RESUMEN

Despite the importance of dopamine signaling, it remains unknown if the two major subclasses of dopamine receptors exist on the same or distinct populations of neurons. Here we used confocal microscopy to demonstrate that virtually all striatal neurons, both in vitro and in vivo, contained dopamine receptors of both classes. We also provide functional evidence for such colocalization: in essentially all neurons examined, fenoldopam, an agonist of the D1 subclass of receptors, inhibited both the Na+/K+ pump and tetrodotoxin (TTX)-sensitive sodium channels, and quinpirole, an agonist of the D2 subclass of receptors, activated TTX-sensitive sodium channels. Thus D1 and D2 classes of ligands may functionally interact in virtually all dopamine-responsive neurons within the basal ganglia.


Asunto(s)
Neostriado/metabolismo , Neuronas/metabolismo , Receptores de Dopamina D1/metabolismo , Receptores de Dopamina D2/metabolismo , Animales , Benzazepinas/farmacología , Células Cultivadas , Antagonistas de los Receptores de Dopamina D2 , Fenoldopam/farmacología , Microscopía Confocal , Neostriado/química , Neostriado/citología , Neostriado/embriología , Neuronas/química , Neuronas/efectos de los fármacos , Quinpirol/farmacología , Ratas , Receptores de Dopamina D1/agonistas , Receptores de Dopamina D1/análisis , Receptores de Dopamina D1/antagonistas & inhibidores , Receptores de Dopamina D2/agonistas , Receptores de Dopamina D2/análisis , Sodio/metabolismo , Agonistas de los Canales de Sodio , Bloqueadores de los Canales de Sodio , Canales de Sodio/metabolismo , ATPasa Intercambiadora de Sodio-Potasio/antagonistas & inhibidores , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Sulpirida/farmacología , Tetrodotoxina/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA